Tuesday, 27 October 2026European Markets

TINC, ALTAMIR, Another 2 Companies Have A High Dividend Yield And Return On Equity In The Asset Management Industry.

Loading stream...

(vianews) - tinc (tinc.br) is among this list of stock assets with the highest dividend rate and return on equity on the asset management industry.

financial asset price forward dividend yield return on equity
tinc (tinc.br) €11.90 4.5% 6.13%
altamir (lta.pa) €27.50 4.28% 12.4%
peugeot invest (peug.pa) €99.40 2.72% 4.8%
hal trust (hal.as) €124.60 1.94% 3.3%

several euronext companies pay out dividends to its shareholders. the dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. tinc (tinc.br)

4.5% forward dividend yield and 6.13% return on equity

tinc comm. va is an investment firm specializing in investments in public and private infrastructure, real assets, and energy sector. tinc comm. va is based in antwerpen, belgium.

earnings per share

as for profitability, tinc has a trailing twelve months eps of €0.78.

pe ratio

tinc has a trailing twelve months price to earnings ratio of 15.26. meaning, the purchaser of the share is investing €15.26 for every euro of annual earnings.

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 6.13%.

more news about tinc.

2. altamir (lta.pa)

4.28% forward dividend yield and 12.4% return on equity

altamir sca formerly known as altamir amboise, is a private equity firm specializing in both direct and fund of fund investments, small and mid-cap companies. in direct investing, the firm specializes in middle market, buyout and growth capital investments. the firm prefers to invest in under-developed divisions of larger corporations. it prefers to invest in private equity funds specializing in growth capital and leverage buyouts investments. the firm typically invests in the following sectors: healthcare, tmt, digital companies, services, retail and distribution. it also invests in retail and consumer, business and financial services. in healthcare, it seeks to focus on companies with strong growth potential in areas such as health services (hospitalization structures, home health care and medical analysis); medical devices; in niche pharmaceutical laboratories; and companies in related activities such as dermo-cosmetics, galenic development, and services and databases for health organizations. the firm seeks to invest in unlisted companies based in europe, with a particular focus on belgium, france, luxembourg, switzerland, monaco, italy, netherlands, germany and french-speaking europe; united states and canada and in larger emerging markets such as china, india and brazil. in small and mid-cap companies firm prefers to invest in continental europe with a focus in france, italy and benelux, & larger size companies in europe, north america and emerging countries like china, india and brazil. in small and mid-cap size companies it prefers to invest with enterprise value between €50 million ($55.36 million) and €500 million ($553.6 million) and in larger size companies it prefers to invest with enterprise value between €500 million ($553.60 million) and €3000 million ($3321.62 million). it invests in funds that seek to have a majority stake in its investments or be a lead shareholder. it invests and disinvests with the private equity funds of apax partners france and amboise investissement under the same conditions and also invests directly in funds managed or advised by apax partners france and apax partners llc. the firm seeks to exit its investments within five years. it makes balance sheet investments. altamir sca was founded in 1995 and is based in paris, france.

earnings per share

as for profitability, altamir has a trailing twelve months eps of €-0.74.

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 12.4%.

volatility

altamir's last week, last month's, and last quarter's current intraday variation average was a negative 1.00%, a negative 0.29%, and a positive 0.98%.

altamir's highest amplitude of average volatility was 1.96% (last week), 1.12% (last month), and 0.98% (last quarter).

stock price classification

according to the stochastic oscillator, a useful indicator of overbought and oversold conditions, altamir's stock is considered to be overbought (>=80).

sales growth

altamir's sales growth is negative 99.4% for the current quarter and negative 99.4% for the next.

dividend yield

as stated by morningstar, inc., the next dividend payment is on may 25, 2022, the estimated forward annual dividend rate is 1.13 and the estimated forward annual dividend yield is 4.28%.

more news about altamir.

3. peugeot invest (peug.pa)

2.72% forward dividend yield and 4.8% return on equity

peugeot invest société anonyme operates as an investment company. the firm invests in private equity and real estate funds. the firm also invests in governance, social, and environmental protection. the company was formerly known as ffp société anonyme and changed its name to peugeot invest société anonyme. peugeot invest société anonyme was incorporated in 1929 and is headquartered in paris, france.

earnings per share

as for profitability, peugeot invest has a trailing twelve months eps of €9.52.

pe ratio

peugeot invest has a trailing twelve months price to earnings ratio of 10.44. meaning, the purchaser of the share is investing €10.44 for every euro of annual earnings.

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 4.8%.

dividend yield

as maintained by morningstar, inc., the next dividend payment is on may 19, 2023, the estimated forward annual dividend rate is 2.85 and the estimated forward annual dividend yield is 2.72%.

sales growth

peugeot invest's sales growth for the current quarter is negative 15.4%.

volatility

peugeot invest's last week, last month's, and last quarter's current intraday variation average was a negative 1.31%, a negative 0.52%, and a positive 1.41%.

peugeot invest's highest amplitude of average volatility was 1.31% (last week), 1.25% (last month), and 1.41% (last quarter).

revenue growth

year-on-year quarterly revenue growth declined by 85.4%, now sitting on 310.12m for the twelve trailing months.

more news about peugeot invest.

4. hal trust (hal.as)

1.94% forward dividend yield and 3.3% return on equity

hal trust, together with its subsidiaries, operates through multi-sectors in europe, the united states, canada, asia, and internationally. the company operates through unquoted, quoted minority interests, real estates, and liquid portfolio segments. it engages in production of composite panels; residential construction, utility construction, project development, and renovation activities; supply of timber products and building materials; and develop, distributes, and e-commerce computer gaming equipment. the company also provides furniture and fit-out services; sells medical and hearing aid products; offers shipping, greenhouse construction, information and data, credit management, and factoring services; and operates temporary staffing agency, optical retail chain, mortgage funding, and greenhouse projects, as well as offers certification and benchmarking human resource polices. in addition, it manufactures and distributes optical frames and sunglasses; and design, builds, installs, and operates offshore floating facilities, as well as provides tank storage services. further, the company engages in the development and rental of retail centers, multi-family properties, and office buildings; and investment in grade bonds; and provision of financial assets, including marketable securities and cash-equivalent instruments. additionally, it invests in ghg reduction projects; and offers financial services, building materials, orthopedic devices, and tank terminal services. the company was founded in 1873 and is based in willemstad, curaçao.

earnings per share

as for profitability, hal trust has a trailing twelve months eps of €7.37.

pe ratio

hal trust has a trailing twelve months price to earnings ratio of 16.91. meaning, the purchaser of the share is investing €16.91 for every euro of annual earnings.

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 3.3%.

volatility

hal trust's last week, last month's, and last quarter's current intraday variation average was a negative 0.72%, a negative 0.02%, and a positive 0.78%.

hal trust's highest amplitude of average volatility was 1.03% (last week), 0.92% (last month), and 0.78% (last quarter).

yearly top and bottom value

hal trust's stock is valued at €124.60 at 22:40 est, below its 52-week high of €135.60 and way above its 52-week low of €107.00.

stock price classification

according to the stochastic oscillator, a useful indicator of overbought and oversold conditions, hal trust's stock is considered to be overbought (>=80).

dividend yield

as stated by morningstar, inc., the next dividend payment is on may 19, 2023, the estimated forward annual dividend rate is 2.5 and the estimated forward annual dividend yield is 1.94%.

more news about hal trust.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biotech Catalyst Window: ESMO Data, the Ivonescimab PDUFA and Small-Cap Delistings
Mid-October to November 2026 is a dense catalyst period for clinical-stage biotech. Positive late-stage readouts (ALOFT-IPF, TELIGAN, MIUDELLA, the duvakitug extension) and the ESMO 2026 presentations lead up to the FDA's 14 November PDUFA date for the ivonescimab BLA. At the opposite end of the market, Spago Nanomedical is moving to delist from Nasdaq First North, which shows how hard it is for micro-cap developers to fund themselves. Value is concentrating in companies with late-stage data and near-term regulatory outcomes.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,500 source documents archived
Query this data → isubstrate.com